Summary Objective Non-Candida albicans (NCA) species now account for a significant part
of clinical candidiasis worldwide. In the present study, epidemiology and antifungal …

Purpose Candida albicans (C. albicans) candidemia has been well reported in previous
studies, while research on non-albicans Candida (NAC) bloodstream infections remains …

Background: The change in epidemiology and antifungal susceptibility has generated
interest of Clinical Microbiologists in identification of Candida up to species level along with …

Objective Candidiasis is the most prevalent fungal infection affecting human and animals all
over the world. This study represents the epidemiological aspects of superficial candidiasis …

Non-albicans Candida (NAC) species cause 35–65% of all candidaemias in the general
patient population. They occur more frequently in cancer patients, mainly in those with …

Candidemia is a growing concern worldwide, and its species distribution has shifted toward
non-albicans Candida in recent decades, especially in patients with malignancy. This study …

OBJECTIVES: To assess the changing epidemiology of candidemia in the 1990s, to
evaluate the clinical implications for the presence of non-Candida albicans in blood, and to …

Candidemia is one of the most common fungal nosocomial infections worldwide. It causes
high mortality and morbidity rate with significant hospital costs due to increased length of …

Candida spp. are responsible for 80% of all systemic fungal infections and are associated
with high mortality rates. This study characterised 79 bloodstream isolates of C. albicans, C …

Various studies have documented a shift in species distribution in Candida bloodstream
infections (BSI), but there are little data from Southeast Asia. This study was performed to …